CSF ACTH and beta-endorphin in infants with West syndrome and ACTH therapy.
Corticotrophin (adrenocorticotropic hormone, ACTH) and beta-endorphin levels of the cerebrospinal fluid (CSF) were determined in 16 infants with the West syndrome during individualized ACTH treatment. Prior to treatment, the levels of CSF ACTH were significantly higher in infants with cryptogenic spasms, normal perinatal events, or normal development than in infants with symptomatic spasms or delayed development. The CSF beta-endorphin levels did not differ among the groups. At response, the infants could be divided into three groups: (1) short-course, low-dose responders with a substantial CSF ACTH decline, (2) long-course, high-dose responders with no such effect (but with a tendency towards an upward incline), and (3) non-responders with no significant CSF ACTH changes. The changes in CSF beta-endorphin were somewhat similar to the changes in CSF ACTH, but the greater variability did not allow statistical significance.
Heiskala
H
H
Children's Hospital, Department of Child Neurology, University of Helsinki, Finland.
D000324:Adrenocorticotropic Hormone / Q000008:administration & dosage* / Q000134:cerebrospinal fluid*; D005260:Female; D006801:Humans; D007223:Infant; D007363:Intensive Care Units, Neonatal / Q000706:statistics & numerical data; D008297:Male; D013036:Spasms, Infantile / Q000134:cerebrospinal fluid* / Q000150:complications / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome; D001615:beta-Endorphin / Q000134:cerebrospinal fluid*
D001615:beta-Endorphin; D000324:Adrenocorticotropic Hormone